A detailed history of M&G PLC transactions in Abb Vie Inc. stock. As of the latest transaction made, M&G PLC holds 360,839 shares of ABBV stock, worth $72.3 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
360,839
Previous 364,822 1.09%
Holding current value
$72.3 Million
Previous $62.7 Billion 13.28%
% of portfolio
0.26%
Previous 0.25%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$163.84 - $199.33 $652,574 - $793,931
-3,983 Reduced 1.09%
360,839 $71.1 Billion
Q2 2024

Jul 16, 2024

BUY
$154.79 - $180.76 $20.9 Million - $24.4 Million
135,111 Added 58.82%
364,822 $62.7 Billion
Q1 2024

May 10, 2024

BUY
$159.82 - $182.1 $36.7 Million - $41.8 Million
229,711 New
229,711 $41.8 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $354B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track M&G PLC Portfolio

Follow M&G PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M&G PLC, based on Form 13F filings with the SEC.

News

Stay updated on M&G PLC with notifications on news.